| scholarly article | Q13442814 |
| P2093 | author name string | Michele Pisano | |
| P2860 | cites work | Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Q22241288 |
| Type 2 diabetes can be prevented with early pharmacological intervention | Q27694430 | ||
| Standards of medical care in diabetes--2014 | Q28304435 | ||
| Correlates of insulin injection omission | Q33602102 | ||
| Insulin delivery using pen devices. Simple-to-use tools may help young and old alike | Q33772803 | ||
| Practical aspects of insulin pen devices | Q33979645 | ||
| Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability | Q34180791 | ||
| Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006 | Q34581681 | ||
| Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment | Q37177927 | ||
| A review of insulin pen devices and use in the elderly diabetic population | Q38033551 | ||
| Relationships between gastric emptying, postprandial glycemia, and incretin hormones | Q38101324 | ||
| Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm | Q38129487 | ||
| AACE comprehensive diabetes management algorithm 2013. | Q43448145 | ||
| TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic control | Q43726758 | ||
| Nurse satisfaction using insulin pens in hospitalized patients | Q44146134 | ||
| A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell | Q44704648 | ||
| Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization | Q47601081 | ||
| Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study | Q50959825 | ||
| Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus | Q50969719 | ||
| Impact of an interchange program to support use of insulin pens. | Q53686525 | ||
| American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus | Q80572896 | ||
| A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens | Q84816225 | ||
| Diagnosis and classification of diabetes mellitus | Q85777959 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 866-876 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | P & T: journal for formulary management | Q15767306 |
| P1476 | title | Overview of insulin and non-insulin delivery devices in the treatment of diabetes | |
| P478 | volume | 39 |
| Q33815567 | Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017. | cites work | P2860 |
Search more.